Mostofi Keyvan, Samii Madjid
Department of Neurosurgery, Clinique Bel Air, 33000 Bordeaux, France.
Department of Neurosurgery, Internationa Neuroscience Institut, Rudolf-Pichlmayr-Straße 4. D - 30625 Hannover, Germany.
Asian J Neurosurg. 2017 Apr-Jun;12(2):194-198. doi: 10.4103/ajns.AJNS_320_16.
This paper presents a new management strategy explaining the process used by implantation of external ventricular drainage (EVD) and very gradual increase of intracranial pressure for treatment of acute hydrocephalus. During the last 30 years' experience in professional practice, the senior author (M.S.) discovered that there are some options of regulations between cerebral spinal fluid (CSF) production and resorption. This theory shows that minimal continuous increase of the CSF pressure as long as the patient general neurological condition is unchanged and appears as normal can lead to definitive treatment of hydrocephalus without needing to set a shunt. Gradual weaning from EVD is used in some neurosurgical centers related to aneurismal subarachnoid hemorrhage only in a way to treat hydrocephalus in the acute phase, but not as an alternative curative treatment for hydrocephalus, and as far as we know this procedure has not been presented to date in medical literature in this form and this purpose.
Between July 2000 and November 2012, 16 patients suffering from acute secondary hydrocephalus were treated by the method described in the International Neurosciences Institute in Hannover (Germany).
The causes of hydrocephalus were brain tumors (12), arteriovenous malformations (2), one cavernoma, and one polytrauma. In 11 patients (68.75%), the procedure led to a complete cure and surgical treatment has been excluded after EVD removal without any risk to the patients.
Minimal gradual increase of CSF pressure by EVD implantation for the treatment of secondary acute communicating hydrocephalus used by senior author as an option is a safe alternative treatment of hydrocephalus and may obviate the need for surgical procedures.
本文提出了一种新的管理策略,解释了通过植入外部脑室引流(EVD)以及非常缓慢地升高颅内压来治疗急性脑积水的过程。在过去30年的专业实践经验中,资深作者(M.S.)发现脑脊液(CSF)生成与吸收之间存在一些调节选项。该理论表明,只要患者的一般神经状况保持不变且看起来正常,脑脊液压力的最小持续升高可导致脑积水的确定性治疗,而无需置入分流管。在一些神经外科中心,仅在治疗动脉瘤性蛛网膜下腔出血急性期的脑积水时采用逐渐撤离EVD的方法,但并非作为脑积水的替代治愈性治疗方法,据我们所知,这种方法迄今尚未以这种形式和目的在医学文献中呈现。
2000年7月至2012年11月期间,16例急性继发性脑积水患者采用德国汉诺威国际神经科学研究所描述的方法进行治疗。
脑积水的病因包括脑肿瘤(12例)、动静脉畸形(2例)、1例海绵状血管瘤和1例多发伤。11例患者(68.75%)通过该方法实现了完全治愈,在拔除EVD后无需进行手术治疗,对患者无任何风险。
资深作者采用的通过植入EVD使脑脊液压力最小程度逐渐升高来治疗继发性急性交通性脑积水的方法,是一种安全的脑积水替代治疗方法,可能无需进行手术。